US authorizes more batches of J&J COVID-19 vaccine made at Emergent | Inquirer News
Close  

US authorizes more batches of J&J COVID-19 vaccine made at Emergent

/ 04:54 AM November 06, 2021
FILE PHOTO: Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton

FILE PHOTO: Johnson & Johnson’s coronavirus disease (COVID-19) vaccines are seen at Northwell Health’s South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton

The U.S. Food and Drug Administration said on Friday it had authorized the use of two more batches of Johnson & Johnson’s one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore factory of Emergent BioSolutions Inc.

The FDA has now authorized 11 batches of the vaccine manufactured at the facility.

ADVERTISEMENT

In April, U.S. authorities halted production after ingredients from AstraZeneca’s COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine.

Today’s authorization was based on a thorough review of facility records and quality testing by the manufacturer, and considering the current COVID-19 public health emergency, the health agency said in a statement.

FEATURED STORIES

An estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made early this year have been sitting idle in the Baltimore plant for weeks awaiting a green light from U.S. regulators to ship, two sources familiar with the matter told Reuters late last month.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus vaccine, Emergent Biosolutions Inc, Johnson & Johnson, US Food and Drug Administration
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.